Stefan Gaubatz
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 04, 2025
Oncogenic YAP sensitizes cells to CHK1 inhibition via CDK4/6 driven G1 acceleration.Dörthe Gertzmann, Cornelius Presek, Anna Lena Mattes
|Jan 05, 2024
Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers.Marco Jessen, Dörthe Gertzmann, Franziska Liss
|Mar 03, 2023
Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration.Maria Camila Fetiva, Franziska Liss, Dörthe Gertzmann
|Sep 22, 2022
Expression of the cytokinesis regulator PRC1 results in p53-pathway activation in A549 cells but does not directly regulate gene expression in the nucleus.Steffen Hanselmann, Dörthe Gertzmann, Woo Jin Shin
|Jun 29, 2021
IQGAP3, a YAP Target, Is Required for Proper Cell-Cycle Progression and Genome Stability.Marina Leone, Salvador Cazorla-Vázquez, Fulvia Ferrazzi
|May 30, 2020
Interaction of YAP with the Myb-MuvB (MMB) complex defines a transcriptional program to promote the proliferation of cardiomyocytes.Marco Gründl, Susanne Walz, Laura Hauf
Pageof 1
Frequent Collaborators
3 joint publications
Marco Jessen
3 joint publications
Carsten P Ade
2 joint publications
Hans Michael Maric
1 joint publications
Laura Hauf
1 joint publications
Melissa Schwab
1 joint publications
Fulvia Ferrazzi
1 joint publications
Silvia Vergarajauregui
1 joint publications
Markus Eckstein
1 joint publications
Felix B Engel
1 joint publications
Clemens Schulte
